Immuneed

Your future preclinical testing begins here

.InfoImageSection-module--image--1gb71.InfoImageSection-module--wide--3A0xd:before { opacity: 1; background-image: url('/static/5b33c34e778c4577531e9c0d236b00b1/3b8af/iStock-494156390-scaled.jpg'); }

Enabling safe & effective drugs

With strong scientific knowledge and a GLP-certified preclinical platform, we provide our customers with a tailored solution in the early stages of drug development, enabling safe and effective drugs.

.InfoImageSection-module--image--1gb71.InfoImageSection-module--wide--3A0xd.gbi--1490380518-gv88gKv1aWogfZGumJoGDq:before { opacity: 1; background-image: url('/static/189f4324251324fdc61e10ab7798b33e/22fce/2022-02-25-Immuneed-4.jpg'); }

ID.Flow

Immuneed’s platform, ID.Flow™ is a powerful alternative to traditional preclinical methods. It allows simultaneous study of safety and function, thereby comprehensively assessing the effect of your drug on hematology, cellular activation and binding, cytokine production, and complement activation. Work with us to access unique technology and provide your preclinical program with human-based data

.InfoImageSection-module--image--1gb71.InfoImageSection-module--wide--3A0xd.gbi--1411334224-sMgzCJzuaEn4PS7AGvxTVd:before { opacity: 1; background-image: url('/static/4297e425802a496de732ee747bc641e9/2456e/iStock-923038872-scaled-e1621591715453.jpg'); }

Your partner in the development of future innovative therapies.

By addressing important questions related to drug safety and immunology, we cut our customers’ costs and add value to drug development projects.